Cita APA

Chia, S. K. L., Martin, M., Holmes, F. A., Ejlertsen, B., Delaloge, S., Moy, B., . . . Chan, A. (2019). PIK3CA alterations and benefit with neratinib: Analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial. Breast Cancer Res.

Chicago Style Citation

Chia, Stephen K. L., et al. "PIK3CA Alterations and Benefit With Neratinib: Analysis From the Randomized, Double-blind, Placebo-controlled, Phase III ExteNET Trial." Breast Cancer Res 2019.

Cita MLA

Chia, Stephen K. L., et al. "PIK3CA Alterations and Benefit With Neratinib: Analysis From the Randomized, Double-blind, Placebo-controlled, Phase III ExteNET Trial." Breast Cancer Res 2019.